Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HP-3040 transdermal tolterodine pharmacokinetics crossover study versus Detrol LA in healthy adult men
NL-OMON37479Active, not recruiting
- Sponsor
- Noven Pharmaceuticals
- Start
- Feb 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of HP-3040 and tolterodine in urinary incontinence (UI), sponsored by Noven Pharmaceuticals. Primary endpoints: Tolterodine pharmacokinetics, 5-hydroxymethyl tolterodine pharmacokinetics and 6 more. Started Feb 2012; status: active, not recruiting.
02
Drugs
HP-3040tolterodine
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on NL-OMON37479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37479.